Remedy Taking a hit why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Remedy Taking a hit why?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jonathan M. Traxler who wrote (590)	8/10/1998 6:57:00 PM
From: VALUESPEC	Read Replies (1) of 763

I picked up some RMDY recently just over $ 13.00. They have some new products out and, I believe, increased R&D which made last quarter's numbers look worse than they might otherwise have looked. They are a leader in their field, though their field is currently under attack by the likes of IBM for the first time. I'm still not sure this company should be given up for dead, and the recent stock buy-back could help keep the stock price up. If it doesn't, I expect to sell out fairly fast. RMDY: $ 12.88b $ 13.00a VALUESPEC valuespec.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next